Search Results 321-330 of 47960 for heart failure
The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure ...
The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure, disease specific biomarkers, symptoms, ...
The purpose of this study is to perform voice recordings of patients hospitalized with acutely decompensated heart failure (ADHF) to explore mechanisms in the ...
They also looked at heart disease deaths among 813 people without the rheumatic disease. Roughly two-thirds of patients studied were women, and the average age ...
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial · Overview.
Abdominal aortic aneurysm · Acute coronary syndrome · Amyloidosis · Aneurysms · Angina · Aortic aneurysm · Aortic dissection · Aortic valve disease ...
... heart failure with iron deficiency and with a reduced ejection fraction. Participation eligibility. Participant eligibility includes age, gender, type and ...
About this study. The purpose of this study is to characterize the ventilatory response to exercise in females with HFrEF and determine if mechanical ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
While genetics does play a role in heart disease, family history does not mean you will have cardiac problems or suffer a stroke.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.